Katia Varani

14.4k total citations · 1 hit paper
302 papers, 11.7k citations indexed

About

Katia Varani is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Katia Varani has authored 302 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 184 papers in Molecular Biology, 178 papers in Physiology and 79 papers in Organic Chemistry. Recurrent topics in Katia Varani's work include Adenosine and Purinergic Signaling (178 papers), Receptor Mechanisms and Signaling (85 papers) and Pharmacological Receptor Mechanisms and Effects (75 papers). Katia Varani is often cited by papers focused on Adenosine and Purinergic Signaling (178 papers), Receptor Mechanisms and Signaling (85 papers) and Pharmacological Receptor Mechanisms and Effects (75 papers). Katia Varani collaborates with scholars based in Italy, United States and Spain. Katia Varani's co-authors include Pier Andrea Borea, Stefania Gessi, Stefania Merighi, Fabrizio Vincenzi, Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Edward Leung, Romeo Romagnoli, Prisco Mirandola and Silvia Pasquini and has published in prestigious journals such as Chemical Reviews, Journal of Biological Chemistry and Circulation.

In The Last Decade

Katia Varani

301 papers receiving 11.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacology of Adenosine Receptors: The State of the Art

2018 553 citations Pier Andrea Borea, Stefania Gessi et al. profile →

Peers

Countries citing papers authored by Katia Varani

Since Specialization

Citations

This map shows the geographic impact of Katia Varani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katia Varani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katia Varani more than expected).

Fields of papers citing papers by Katia Varani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katia Varani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katia Varani. The network helps show where Katia Varani may publish in the future.

Co-authorship network of co-authors of Katia Varani

This figure shows the co-authorship network connecting the top 25 collaborators of Katia Varani. A scholar is included among the top collaborators of Katia Varani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katia Varani. Katia Varani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 2024 ·Journal of Pineal Research ·Annalida Bedini, (unknown), (unknown), Michele Retini, Laura Scalvini, Silvia Pasquini, Chiara Contri, Katia Varani, Gilberto Spadoni, Marco Mor, Fabrizio Vincenzi, Silvia Rivara	3
2	Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents 2024 ·International Journal of Molecular Sciences ·Elena Mariotto, (unknown), (unknown), Andrea Brancale, Ernest Hamel, Katia Varani, Fabrizio Vincenzi, (unknown), (unknown), Giampietro Viola, Romeo Romagnoli	3
3	2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A₁ Adenosine Receptor Positive Allosteric Modulators 2023 ·ACS Medicinal Chemistry Letters ·Paola Oliva, (unknown), Silvia Pasquini, Veronica Salmaso, E.J. Will, Dilip K. Tosh, Zhan‐Guo Gao, Naili Liu, Oksana Gavrilova, Fabrizio Vincenzi, Katia Varani, Kenneth A. Jacobson	0
4	Pioneering first‐in‐class FAAH‐HDAC inhibitors as potential multitarget neuroprotective agents 2023 ·Archiv der Pharmazie ·(unknown), (unknown), (unknown), Chiara Contri, (unknown), Silvia Pasquini, Gabriele Carullo, Anna Ramunno, Sandra Gemma, Katia Varani, Stefania Butini, Giuseppe Campiani, Fabrizio Vincenzi	4
5	In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice 2022 ·International Journal of Molecular Sciences ·Micaela Tirri, Raffaella Arfè, Sabrine Bilel, (unknown), (unknown), Anna Fantinati, Fabrizio Vincenzi, Fabio De‐Giorgio, (unknown), Monica Mazzarino, Mario Barbieri, Rosa Maria Gaudio, Katia Varani, Pier Andrea Borea, Francesco Botrè, Matteo Marti	13
6	Behavioral and binding studies on the quinolinyl ester indoles 5F-PB22 (5F-QUPIC) and BB-22 (QUCHIC) in the mouse model 2022 ·SHILAP Revista de lepidopterología ·(unknown), Micaela Tirri, Raffaella Arfè, Sabrine Bilel, (unknown), Adolfo Gregori, (unknown), Fabrizio Vincenzi, Fabio De‐Giorgio, Pier Andrea Borea, Katia Varani, Matteo Marti	8
7	4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives 2022 ·Pharmaceuticals ·Daniela Catarzi, Flavia Varano, (unknown), (unknown), Fabrizio Melani, Katia Varani, Fabrizio Vincenzi, Silvia Pasquini, Natascia Mennini, (unknown), Diego Dal Ben, Rosaria Volpini, Vittoria Colotta	5
8	A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease 2021 ·Cells ·Stefania Gessi, Tino Emanuele Poloni, (unknown), Katia Varani, Silvia Pasquini, Fabrizio Vincenzi, Pier Andrea Borea, Stefania Merighi	23
9	The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation 2020 ·Cells ·Fabrizio Vincenzi, Silvia Pasquini, Stefania Gessi, Stefania Merighi, Romeo Romagnoli, Pier Andrea Borea, Katia Varani	10
10	Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents 2020 ·Bioorganic & Medicinal Chemistry Letters ·Flavia Varano, Daniela Catarzi, Fabrizio Vincenzi, Silvia Pasquini, Julie Pelletier, Juliana Lopes Rangel Fietto, Nicolly Espíndola Gelsleichter, (unknown), (unknown), Jean Sévigny, Katia Varani, Vittoria Colotta	14
11	Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity 2019 ·Journal of Medicinal Chemistry ·(unknown), Daniela Catarzi, Flavia Varano, Matteo Falsini, Katia Varani, Fabrizio Vincenzi, Silvia Pasquini, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Elena Lucarini, Diego Dal Ben, Andrea Spinaci, Gianluca Bartolucci, Marta Menicatti, Vittoria Colotta	18
12	Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2A adenosine receptor 2018 ·European Journal of Medicinal Chemistry ·Flavia Varano, Daniela Catarzi, Fabrizio Vincenzi, Matteo Falsini, Silvia Pasquini, Pier Andrea Borea, Vittoria Colotta, Katia Varani	12
13	Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1 and A2A adenosine receptor antagonists/inverse agonists 2018 ·Bioorganic & Medicinal Chemistry ·Flavia Varano, Daniela Catarzi, Matteo Falsini, Fabrizio Vincenzi, Silvia Pasquini, Katia Varani, Vittoria Colotta	14
14	The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor 2018 ·European Journal of Medicinal Chemistry ·(unknown), Daniela Catarzi, Flavia Varano, Matteo Falsini, Katia Varani, Fabrizio Vincenzi, Diego Dal Ben, Catia Lambertucci, Vittoria Colotta	28
15	Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 2015 ·Neuropharmacology ·(unknown), Andrea Ossato, Claudio Trapella, Fabrizio Vincenzi, Claudia Rimondo, Catia Seri, Katia Varani, Giovanni Serpelloni, Matteo Marti	82
16	A _2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 2013 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Fabrizio Vincenzi, Carmen Corciulo, Martina Targa, Ilaria Casetta, Mauro Gentile, Enrico Granieri, Pier Andrea Borea, Patrizia Popoli, Katia Varani	34
17	Functional Tissue Engineering in Articular Cartilage Repair: Is There a Role for Electromagnetic Biophysical Stimulation? 2013 ·Tissue Engineering Part B Reviews ·Milena Fini, Stefania Pagani, Gianluca Giavaresi, Monica De Mattei, Alessia Ongaro, Katia Varani, Fabrizio Vincenzi, Leo Massari, Matteo Cadossi	50
18	A3 Receptors Are Overexpressed in Pleura from Patients with Mesothelioma and Reduce Cell Growth via Akt/Nuclear Factor-κB Pathway 2010 ·American Journal of Respiratory and Critical Care Medicine ·Katia Varani, (unknown), Fabrizio Vincenzi, Martina Targa, (unknown), Pio Maniscalco, Fernanda Martini, Mauro Tognon, Pier Andrea Borea	39
19	Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography 2000 ·Sergio Todde, (unknown), Pasquale Simonelli, P. G. BARALDI, Barbara Cacciari, Giampiero Spalluto, Katia Varani, Angela Monopoli, Mario Matarrese, Ângelo Rafael Carpinelli, Fulvio Magni, M. Galli Kienle, Ferruccio Fazio	4
20	C-Nucleosides analogues of oxazofurin as selective agonists for adenosine A1 receptors 1998 ·Drug Development Research ·Loredana Cappellacci, Mario Grifantini, Claudia Martini, Antonio Lucacchini, Katia Varani, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact